Bay Area biotechs soar on coattails of AstraZeneca cancer drug study
September 17, 2021 at 17:59 PM EDT
The companies have drugs in clinical trials that target an enzyme implicated in poor prognosis for patients.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|